Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EXACT Sciences
MedTech
Abbott lowers EPS guidance on Exact Sciences buy as shares slide
Abbott's first-quarter numbers reflect is operational complexity.
Ben Adams
Apr 17, 2026 9:01am
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Nov 20, 2025 10:30am
Exact Sciences rolls out Cancerguard multi-cancer blood test
Sep 11, 2025 1:00pm
Exact Sciences plans 'transformative year' with new cancer tests
May 1, 2025 4:05pm
Exact Sciences kicks off launch of next-gen Cologuard Plus test
Mar 31, 2025 6:00am
FDA approves Exact Sciences’ next-gen Cologuard Plus home test
Oct 4, 2024 12:30pm
